CLINICAL TRIAL, SINGLE BLIND, RANDOMIZED, CONTROLLED PROSPECTIVE EVALUATION FOR OPTIMUM TIME INTERVAL BETWEEN ACETATE ADMINISTRATION AND PUNCTURE TRIPTORELIN FOLLICULAR IN IVF TREATMENT

INSTITUTO DE INVESTIGACION SANITARIA LA FE0 个研究点目标入组 176 人开始时间: 2013年6月25日最近更新: 2018年4月30日

适应症

试验速览

暂无简介。

•Age less than or equal to 37 years. Sterility of tubal origin, unknown or treatable
•male factor IVF / ICSI using ejaculated semen (including frozen semen donor).
•Blood levels of basal FSH <10 mIU / ml on day 3 of the menstrual cycle. Serum
•AMH> 5 and <45 pmol / l Number of antral follicles> 6 and <24 between both
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 176
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Diagnosis of endometriosis severe (Grade III-IV). Diagnosis of SDM. polycystic
•ovaries (defined according to the Rotterdam criteria). History of low response in
•ovarian stimulation cycles prior defined as presence of less than 4 follicles greater
•than 16 mm or canceled cycle. All those patients who do not voluntarily give their
•express written consent Known allergy to the drug

发起方

INSTITUTO DE INVESTIGACION SANITARIA LA FE